Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R White

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|July 1, 1977
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidineG J Durant, J C Emmett, C R Ganellin, et al.
Journal of Medicinal Chemistry|October 1, 1985
The histamine H2 receptor agonist impromidine: synthesis and structure-activity considerationsG J Durant, C R Ganellin, D W Hills, et al.
Human Genetics|June 1, 1995
Genome-wide loss of maternal alleles in a nephrogenic rest and Wilms' tumour from a BWS patientP R Hoban, J Heighway, G R White, et al.
British Journal of Cancer|October 29, 1998
A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrierJ M Varley, G McGown, M Thorncroft, et al.
American Journal of Human Genetics|April 1, 1993
A linkage study in seven breast cancer familiesM D Teare, M F Santibáñez-Koref, S A Wallace, et al.
British Journal of Cancer|September 1, 1996
High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressorG R White, M Stack, M Santibáñez-Koref, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 7, 2013
Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle lossM Sheffield-Moore, E L Dillon, K M Randolph, et al.
Oncogene|July 29, 1998
Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like familyJ M Varley, P Chapman, G McGown, et al.
Physical Review Letters|February 4, 2014
Experimental validation of a novel compact focusing scheme for future energy-frontier linear lepton collidersG R White, R Ainsworth, T Akagi, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Journal of Medicinal Chemistry|July 1, 1977
Cyanoguanidine-thiourea equivalence in the development of the histamine H2-receptor antagonist, cimetidineG J Durant, J C Emmett, C R Ganellin, et al.
Journal of Medicinal Chemistry|October 1, 1985
The histamine H2 receptor agonist impromidine: synthesis and structure-activity considerationsG J Durant, C R Ganellin, D W Hills, et al.
Human Genetics|June 1, 1995
Genome-wide loss of maternal alleles in a nephrogenic rest and Wilms' tumour from a BWS patientP R Hoban, J Heighway, G R White, et al.
British Journal of Cancer|October 29, 1998
A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrierJ M Varley, G McGown, M Thorncroft, et al.
American Journal of Human Genetics|April 1, 1993
A linkage study in seven breast cancer familiesM D Teare, M F Santibáñez-Koref, S A Wallace, et al.
British Journal of Cancer|September 1, 1996
High levels of loss at the 17p telomere suggest the close proximity of a tumour suppressorG R White, M Stack, M Santibáñez-Koref, et al.
Journal of Cachexia, Sarcopenia and Muscle|September 7, 2013
Isotopic decay of urinary or plasma 3-methylhistidine as a potential biomarker of pathologic skeletal muscle lossM Sheffield-Moore, E L Dillon, K M Randolph, et al.
Oncogene|July 29, 1998
Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like familyJ M Varley, P Chapman, G McGown, et al.
Physical Review Letters|February 4, 2014
Experimental validation of a novel compact focusing scheme for future energy-frontier linear lepton collidersG R White, R Ainsworth, T Akagi, et al.
Pageof 4